Induced Pluripotent Stem Cells – Generation and Cultivation

Induced pluripotent stem cells (iPSCs) are pluripotent stem cells, derived by transducing a specific set of pluripotency-associated genes, or “reprogramming factors” into an adult cell type.

 

These cells show qualities very similar to human embryonic stem cells. Since iPSCs derived directly from adult tissues, they have the potential to differentiate into tissues. This process not only bypasses the need for embryos but can be grown into tissue individually.

How to generate iPSCs?

There are multiple ways to generate iPSCs, including retrovirus or lentivirus-mediated gene transduction and chemical induction.

The original set of reprogramming factors (also called Yamanaka factors) consists of the genes Oct4 (Pou5f1), Sox2, cMyc, and Klf4, using a retroviral system. The retroviral vectors require integration into host chromosomes to express reprogramming genes, but DNA-based vectors and plasmid vectors do not generally integrate into the cell genome. At the same time, Thomson and colleagues derived human embryonic stem cells by using a lentiviral system with a different set of factors: Oct4, Sox2, Nanog, and Lin28.

 

the derivation of iPSC

 

Pic 1. the derivation of iPSC

iPSC Generation Difficulty and Solution

iPSC generation is a slow process, and its conversion rate is incredibly low. It takes 1–2 weeks for mouse cells and 3–4 weeks for human cells with the efficiencies as low as 0.01–0.1%. Recently, some optimizations have been made in improving the efficiency and reducing iPSCs derivation time.

 

Traditionally, the specific fibroblast feeder layers are necessary for the human embryonic stem cells (hESC cells) and human iPSCs culture. The feeder cell preparation requires significant time and effort, can become very labor-intensive and hard to scale. Researchers have developed feeder-free systems for both hES and hiPS cell culture. Extracellular matrix (ECM) proteins such as Matrigel, vitronectin are added into these systems. These ingredients can reduce, even completely separate serum from hESCs and hiPSCs culture without weakening cell activity. To move forward this process, researchers have also designed medium without the requirement of feeder layer cells.

 

Recently a path involved with Mbd3 was found, which closely related to the reprogramming efficiency. Mbd3 is a subunit of deacetylation (NuRD) that inhibits iPSCs induction. Upon Mbd3 depletion, reprogramming factors are recruited into downstream targets (e.g., pluripotency-related genes) to enhance gene expression, leads to highly efficient the reprogramming to pluripotency. The WDR5 and UTX are essential in reprogramming of Mbd3 -depleted MEFs.

Reprogramming performance can be improved by the consumption of Mbd3, results in iPSC cell reprogramming deterministic and synchronized. The efficiency can also be enhanced significantly to nearly 100% within seven days, from both mouse and human cells.

 

The mechanism of proposed Mbd3/NuRD related reprogramming

 

Pic2. The mechanism of proposed Mbd3/NuRD related reprogramming

How to Culture iPSCs?

We recommend you plate on feeder layer cells. The plating Mouse Embryonic Fibroblasts (MEFs) is mostly used and proved to help keep the stability and viability of our iPSCs. MEFs density ranges from 1 x 105 to 4 x 105 cells in each well (6-well plate). However, the exact MEF density should be determined by individual lab environments. Here we suggest determining MEF density: thaw and plate MEFs at varying densities, ranging from 1 x 105 to 4 x 105 per well. IPSCs were passaged to MEFs and sustained for 5 days, and the tests of morphology, growth rate, and alkaline phosphatase expression were performed to evaluate the iPSC undifferentiated rate maintained by MEFs in each well.

 

The MEFs should be plated on gelatin 1 day before iPSC plating or at least for 8 hours to ensure optimized density.

The cryopreserved iPSCs should be recovered by 37℃ water bath, then dropwise to 10ml warm medium, mixed and centrifuged. Re-suspend cells medium should be supplemented with 10μM Rho kinase inhibitor(Y-compound), then plated and evenly distributed into MEF covered 6-well plate. The replacement of the new medium without the Y compound should be completed within 20 hours.

iPSC-related Researches and Prospects

 

The brief introduction of inducing and research using of iPSCs

 

Pic3. The brief introduction of inducing and research using of iPSCs

 

Nowadays, iPSCs have already become a useful tool for disease modeling and drug development, and it shows great potential in transplantation medicine research. Viruses are currently used to introduce reprogramming factors into adult cells. Sometimes in animal studies, the virus used to introduce the stem cell factors possibly causes cancers. We must be carefully controlled and tested before its application into the treatment for humans.

 

Researchers are currently investigating non-viral delivery strategies. Related transcription factors like miRNAs or small molecules can also be used to replace each of the pluripotency factors for the generation of the iPSCs.

 

As a well-deserved breakthrough, the iPSC makes cell de-differentiates move one step further. Besides, tissues generated with iPSCs significantly and identically improves the match to the cell donor, probably avoid the immune system rejection. The iPSC can create pluripotent stem cells that possibly develop into any specified cell type, help researchers with cell reprogram and tissue repair in the human body.

AcceGen iPSCs

More research is demanded to discover how much iPSCs could contribute. AcceGen would like to help relative researches to move forward by developing a wider variety of iPSCs products. At the moment, AcceGen has programmed some common starting cell types. We provide iPSCs for donors of different ages, health status, etc. Please see the link below:

https://www.accegen.com/category/induced-pluripotent-stem-cells-ipscs/

 

For quotations or more information about iPSC products, please call us at 1-862-686-2696 or send an email to inquiry@accegen.com. If neither iPSC meets your demand, our tech support team will help you look for the most suitable product or customize service according to your requirements. Your questions and requests will be answered by the expert staff at AcceGen within 24 hours.

Comments

Post a Comment

Popular posts from this blog

Cancer associated fibroblasts: how do they contribute to cancer progression?

Image
Cancer associated fibroblasts (CAFs), or Carcinoma associated fibroblasts, can contribute to cancer progression through multiple mechanisms, including the secretion of soluble factors and extracellular matrix, physical interactions with cancer cells, the regulation of  angiogenesis , immunity and metabolism, and resistance to chemoprevention according to many present researches. Therefore, CAFs are attracting increasing attention as a therapeutic target in cancer. What is CAF s ? Tumors are multicellular tissues consisting of not only tumor cells but also resident cells in the local stroma. Fibroblasts are a significant portion to the cell composition of most solid tumors, including prostate cancer, lung cancer, breast cancer, gastric cancer, colorectal cancer, and pancreatic cancer. CAF cells, which mainly originate from local tissue fibroblasts, are a heterogeneous population of activated fibroblasts found within the tumor microenviron...
Read more

Application of MDA-MB-series Cell Lines in Breast Cancer Research

Image
The Relationship between Breast Cancer and Breast Cancer Cells Breast cancer  is the leading cause of cancer death among women in developed countries[1]. The majority of breast cancer patients are over 50 years old. However, the result of new cases study shows that the number of breast cancer patients under 45 years old has exceeded 10%[2].   Currently, most of the breast cancer knowledge comes from in vivo and in vitro studies using  breast cancer cell lines  because they can provide unlimited amounts of homologous self-replicating material using simple but standard media[3]. Therefore, it is essential to know whether these cell lines can capture molecules well before obtaining any clinically relevant results.   Breast Cancer MDA-MB-series Cell Lines Establishment MDA-MB- series tumor cell lines were established from M. D. Anderson Hospital and Tumor Institute. They have created a total of 19 MDA-MB series of cell lines from female patients ...
Read more

Bone Cancer and Bone Cancer Cell Lines

Image
Bone and Bone Cancer Bone The bone is a rigid organ that protects other organs and supports the body[1, 2]. There are about 300 bones in a newborn baby, and some of them will fuse during growth and development, and finally, 206 pieces are left in adulthood[3]. The main structures of bones include the outer cortex composed of dense bone[4], internal cortical bone[5], marrow[6], and cells[5]. Bones have a variety of functions, including a variety of mechanical functions[7], the Synthetic function of bone marrow ( hematopoiesis )[8], and are involved in body metabolism (such as mineral and fat storage,  pH balance regulation , detoxication, and calcium balance regulation). Besides, some diseases or injuries also occur in the bones, such as fractures, tumors, osteoporosis, etc.[9].     Figure.1  Microstructure of bone tissue   Tumor and  B one Cancer Bone has the possibility of tumorigenesis, which may affect the bones to a certain extent. Benign tumors are mos...
Read more